Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Early research (Phase 1)Ended earlyNCT07029971
What this trial is testing

A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Vial Australia Pty Ltd 16
Large-scale testing (Phase 3)Study completedNCT02038920
What this trial is testing

Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 157
Large-scale testing (Phase 3)Study completedNCT00543374
What this trial is testing

Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 98
Not applicableStudy completedNCT00791557
What this trial is testing

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Who this might be right for
Pyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more
University Hospitals Cleveland Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00265122
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 131
Testing effectiveness (Phase 2)Study completedNCT00771667
What this trial is testing

Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Who this might be right for
Crohn's Disease
Centocor, Inc. 526
Testing effectiveness (Phase 2)Ended earlyNCT01671956
What this trial is testing

Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis, Active ModerateUlcerative Colitis, Active Severe
Alexion Pharmaceuticals, Inc. 32
Large-scale testing (Phase 3)UnknownNCT01817972
What this trial is testing

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gastroenterology Research of America 65
Large-scale testing (Phase 3)UnknownNCT01494857
What this trial is testing

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Clalit Health Services 200